Oncimmune Holdings plc (ONC.L) (LON:ONC) insider Cheung To sold 40,000 shares of Oncimmune Holdings plc (ONC.L) stock in a transaction that occurred on Monday, January 11th. The shares were sold at an average price of GBX 185 ($2.42), for a total transaction of £74,000 ($96,681.47).
Cheung To also recently made the following trade(s):
- On Friday, January 8th, Cheung To sold 10,000 shares of Oncimmune Holdings plc (ONC.L) stock. The stock was sold at an average price of GBX 185 ($2.42), for a total value of £18,500 ($24,170.37).
Shares of ONC stock opened at GBX 189 ($2.47) on Thursday. Oncimmune Holdings plc has a twelve month low of GBX 30 ($0.39) and a twelve month high of GBX 200 ($2.61). The company has a current ratio of 1.80, a quick ratio of 1.74 and a debt-to-equity ratio of 375.32. The stock has a fifty day simple moving average of GBX 169.49 and a two-hundred day simple moving average of GBX 154.75. The stock has a market capitalization of £120.32 million and a price-to-earnings ratio of -14.10.
Oncimmune Holdings plc develops and commercializes products to diagnose cancer in the United Kingdom, North America, Europe, and internationally. It offers EarlyCDT-Lung, a blood test for early detection of lung cancer. The company also develops EarlyCDT-Liver, a blood test for the early detection of hepatocellular carcinoma in high-risk patients with liver lesions of all sizes; SeroTag, a platform that is used to discover and validate biomarkers and develop precision diagnostic tools from minimally-invasive liquid biopsies; and NavigAID for autoimmune diseases.
Further Reading: How is a management fee different from a performance fee?
Receive News & Ratings for Oncimmune Holdings plc (ONC.L) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oncimmune Holdings plc (ONC.L) and related companies with MarketBeat.com's FREE daily email newsletter.